Roche nominates ex-Takeda CEO Christophe Weber for board election at 2027 AGM

23. Sep 2026

Description

(AWP Alliance News) - Roche Holding AG will ask shareholders at its Annual General Meeting on March 9, 2027 to elect former Takeda Pharmaceuticals CEO Dr. Christophe Weber to its board of directors. The board has endorsed Weber's nomination, citing his healthcare industry expertise and leadership background.

https://www.globenewswire.com/NewsRoom/ReleaseNg/402516324

Disclaimer: This news brief was created using generative artificial intelligence. Roche Holding AG published the original content used to generate this news brief via GlobeNewswire on September 23, 2026, and is solely responsible for the information contained therein.